#52 – Right-Wing Psychedelia at University of Madison-Wisconsin

June 27, 2022

This talk was presented live by Dr. Brian Pace and Dr. Neşe Devenot at the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances. This talk was presented on April 28 as part of the “Psychedelic Humanities” speaker series, organized by Dr. Lucas Richert.

Public discourse concerning psychedelics and the emerging industry in psychedelic-assisted therapy has extended beyond the potential benefits of novel treatments for specific mental health disorders to claims that widespread psychedelic use may tilt social relations towards more egalitarian norms. Researchers and media outlets have pointed to several recent studies which present data asserting that classical psychedelics can reduce authoritarianism, increase liberal views, and deepen nature-relatedness.

Taken together, these studies are cited to promote a vision of drug-assisted social progress. Yet counter examples abound of psychedelic-experienced individuals expressing views explicitly opposed to egalitarianism and liberal politics. Moreover, acceptance of psychedelics by institutions and aspirational business and celebrity figures has only increased right-wing psychedelic interest in recent years.

This presentation highlights the numerous contemporary and historical cases where the use of psychedelics failed to reduce authoritarian tendencies in users, or even facilitated adoption of authoritarian views. We demonstrate that psychedelics can catalyze change in political or religious belief, but not in a consistent direction. Instead, we propose that many transformative experiences—including those induced by psychedelics—can challenge and radically shift a person’s worldview, and that extra-pharmacological factors influence the character of change in ideology or political belief.

#52 – Right-Wing Psychedelia at University of Madison-Wisconsin

This talk was presented live by Dr. Brian Pace and Dr. Neşe Devenot at the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances. This talk was presented on April 28 as part of the “Psychedelic Humanities” speaker series, organized by Dr. Lucas Richert.

Plus Three|June 27, 2022

Public discourse concerning psychedelics and the emerging industry in psychedelic-assisted therapy has extended beyond the potential benefits of novel treatments for specific mental health disorders to claims that widespread psychedelic use may tilt social relations towards more egalitarian norms. Researchers and media outlets have pointed to several recent studies which present data asserting that classical psychedelics can reduce authoritarianism, increase liberal views, and deepen nature-relatedness.

Taken together, these studies are cited to promote a vision of drug-assisted social progress. Yet counter examples abound of psychedelic-experienced individuals expressing views explicitly opposed to egalitarianism and liberal politics. Moreover, acceptance of psychedelics by institutions and aspirational business and celebrity figures has only increased right-wing psychedelic interest in recent years.

This presentation highlights the numerous contemporary and historical cases where the use of psychedelics failed to reduce authoritarian tendencies in users, or even facilitated adoption of authoritarian views. We demonstrate that psychedelics can catalyze change in political or religious belief, but not in a consistent direction. Instead, we propose that many transformative experiences—including those induced by psychedelics—can challenge and radically shift a person’s worldview, and that extra-pharmacological factors influence the character of change in ideology or political belief.

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.

Previous episodes


#10 – This Is What Psychedelic Mainstreaming Looks Like

It's not the Hokey Pokey, but psychedelic mainstreaming seems to be what it's all about. We explore some of the realities and questions of what it means to take psychedelics "mainstream.”

#9 – Lucy In the Sky with Nazis

We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.

#8 – Manufacturing Authority

Well, it’s official, psychedelics have entered the corporate-wellness mainstream. If you have any doubts, check out Gwyneth Paltrow’s new Netflix series, The Goop Lab. Or maybe don’t.

#7 – Why We Do What We Do

The team shares their personal stories and talk about how and why they became involved in psychedelic advocacy and drug policy reform. Happy New Year y’alls.

#6 – Abusing Power: Taking Predatory Daniel Pinchbeck At His Word

Pinchbeck has made it exhaustingly clear in his own words that as soon as he gained a modicum of power and status, he used it to exploit women. Why are some members of the psychedelic community so insistent that he get it back?

#5 – Psychedelics X Climate Crisis

The team explores the Psychedelic/Climate-Change connection, and tools for addressing existential crisis. Climate change is the challenge of our era, but the media still distracts us with comparatively trivial matters.

#4 – Psilocybin Incorporated

The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

#3 – Live From Brooklyn: The Set and Setting of the Psychedelic Renaissance is Capitalism

Live from Brooklyn, New York, the team discusses psychedelic science unfolding in a capitalist culture and deconstructs the 'Standard Story' of psychedelic medicalization. They also talk about incoming corporations seeking to capitalize on psychedelic medicines, and ongoing decriminalization efforts across the country.

#2 – Decriminalization Now!

The historical record is clear - drug prohibition is directly connected to the prosecution of minorities: ethnic or political. Not only do we see a complete lack of scientific or evidentiary basis for prohibition and criminalization, we can see it has been a product of white supremacy, xenophobia, misogyny, and imperialism. 

#1 – We Hope Michael Pollan Changes His Mind

Michael Pollan thinks we’re not ready to decriminalize psilocybin, despite his media tour where he capitalized on the rising wave of psychedelic normalization. The team critically examines his New York Times op-ed where he urges caution, and why we think he's wrong.

Previous episodes


#10 – This Is What Psychedelic Mainstreaming Looks Like

It's not the Hokey Pokey, but psychedelic mainstreaming seems to be what it's all about. We explore some of the realities and questions of what it means to take psychedelics "mainstream.”

#9 – Lucy In the Sky with Nazis

We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.

#8 – Manufacturing Authority

Well, it’s official, psychedelics have entered the corporate-wellness mainstream. If you have any doubts, check out Gwyneth Paltrow’s new Netflix series, The Goop Lab. Or maybe don’t.

#7 – Why We Do What We Do

The team shares their personal stories and talk about how and why they became involved in psychedelic advocacy and drug policy reform. Happy New Year y’alls.

#6 – Abusing Power: Taking Predatory Daniel Pinchbeck At His Word

Pinchbeck has made it exhaustingly clear in his own words that as soon as he gained a modicum of power and status, he used it to exploit women. Why are some members of the psychedelic community so insistent that he get it back?

#5 – Psychedelics X Climate Crisis

The team explores the Psychedelic/Climate-Change connection, and tools for addressing existential crisis. Climate change is the challenge of our era, but the media still distracts us with comparatively trivial matters.

#4 – Psilocybin Incorporated

The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

#3 – Live From Brooklyn: The Set and Setting of the Psychedelic Renaissance is Capitalism

Live from Brooklyn, New York, the team discusses psychedelic science unfolding in a capitalist culture and deconstructs the 'Standard Story' of psychedelic medicalization. They also talk about incoming corporations seeking to capitalize on psychedelic medicines, and ongoing decriminalization efforts across the country.

#2 – Decriminalization Now!

The historical record is clear - drug prohibition is directly connected to the prosecution of minorities: ethnic or political. Not only do we see a complete lack of scientific or evidentiary basis for prohibition and criminalization, we can see it has been a product of white supremacy, xenophobia, misogyny, and imperialism. 

#1 – We Hope Michael Pollan Changes His Mind

Michael Pollan thinks we’re not ready to decriminalize psilocybin, despite his media tour where he capitalized on the rising wave of psychedelic normalization. The team critically examines his New York Times op-ed where he urges caution, and why we think he's wrong.

Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

Privacy. Terms of Use. © Psymposia, Inc. All Rights Reserved

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1